Heather A. Wakelee is a professor of oncology at Stanford University Medical Center.[1] Her research focuses on lung cancer.

Wakelee received a Bachelor's degree in molecular biology from Princeton University in 1992 and and MD from Johns Hopkins University in 1996. She is a member of Alpha Omega Alpha.[2] She served as an intern, as a resident in internal medicine, and as a fellow in oncology at Stanford from 1997 to 2003. She was appointed as a staff physician in 2003.[3]

Wakelee is an author on over 180 papers related to cancer research.[4] In 2003, she was give a Merit Award from the American Society of Clinical Oncology.[2]

She is the lead investigator on the ECOG-ARIN clinical trials group at Stanford, and was given a Young Investigator Award from ECOG-ARIN in 2015.[4] She serves on the board of directors of the International Association for the Study of Lung Cancer.[5]

References

  1. ^ "Heather Wakelee". stanfordhealthcare.org. Retrieved 1 May 2019.
  2. ^ a b "Heather Wakelee". Retrieved 1 May 2019.
  3. ^ "Dr. Wakelee - Lung Cancer Oncologist & Researcher". Mesothelioma Center - Vital Services for Cancer Patients & Families. Retrieved 1 May 2019.
  4. ^ a b Zhang, Kaiping (December 2017). "Professor Heather A. Wakelee: facing new progress in lung cancer research, keep in mind how do we best help patients". Translational Lung Cancer Research. 6 (Suppl 1): S108–S110. doi:10.21037/tlcr.2017.11.07. ISSN 2218-6751. Retrieved 1 May 2019.((cite journal)): CS1 maint: unflagged free DOI (link)
  5. ^ "Heather Wakelee | International Association for the Study of Lung Cancer". www.iaslc.org. Retrieved 1 May 2019.